EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 3.0

Acute-on-chronic liver failure: Terminology, mechanisms and management

Vinay Kumar Br, Shiv Kumar Sarin

Clinical and Molecular Hepatology · 01.07.2023 · 29 (3) · 670-689

DOI: 10.3350/cmh.2022.0103 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical and Molecular Hepatology, erschienen am 01.07.2023. Verfasst von Vinay Kumar Br und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatology, Institute of Liver and Biliary Sciences, New Delhi, India. Hauptthemen laut MEDLINE: Acute-On-Chronic Liver Failure, End Stage Liver Disease, Hepatic Encephalopathy. Die Arbeit wurde bisher 123-mal zitiert (Crossref) und nennt 98 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acute-on-chronic liver failure is an acute deterioration of liver function manifesting as jaundice and coagulopathy with the development of ascites, with a high probability of extrahepatic organ involvement and high 28-day mortality. The pathogenesis involves extensive hepatic necrosis, which is associated with severe systemic inflammation and subsequently causes the cytokine storm, leading to portal hypertension, organ dysfunction, and organ failure. These patients have increased gut permeability, releasing lipopolysaccharide (LPS) and damage-associated molecular patterns (DAMPS) in the blood, leading to hyper-immune activation and the secretion of cytokines, followed by immune paralysis, causing the development of infections and organ failure in a proportion of patients. Early detection and the institution of treatment, especially in the "Golden Window" period of 7 days, gives an opportunity for reversal of the syndrome. Scores like the Asian Pacific Association for the Study of the Liver (APASL) ACLF research consortium (AARC) score, a model for end stage liver disease (MELD), and the CLIF Consortium acute-on-chronic liver failure (CLIF-C ACLF) score can help in the prediction of mortality. Treatment strategy includes treatment of acute insult. Patients should be considered for early transplant with MELD score >28, AARC score >10, high-grade hepatic encephalopathy, and in the absence of >2 organ failure or overt sepsis to improve survival of up to 80% at five years. Patients, with no option of transplant, can be treated with emerging therapies like faecal microbial transplant, plasma exchange, etc., which need further evaluation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acute-On-Chronic Liver FailureEnd Stage Liver DiseaseHepatic EncephalopathyHumansSeverity of Illness IndexPrognosis

Stichwörter der Autor:innen

Acute-on-chronic liver failureBile acid and saltsOrgan failurePlasma exchange and support system

Autor:innen und Institutionen

  • Department of Hepatology, Institute of Liver and Biliary Sciences, New Delhi, India.

Zitieren

APA

Br, V. K., & Sarin, S. K. (2023). Acute-on-chronic liver failure: Terminology, mechanisms and management. Clinical and Molecular Hepatology, 29(3), 670-689. https://doi.org/10.3350/cmh.2022.0103

Vancouver

Br VK, Sarin SK. Acute-on-chronic liver failure: Terminology, mechanisms and management. Clinical and Molecular Hepatology. 2023;29(3):670-689. doi:10.3350/cmh.2022.0103

BibTeX
@article{Br2023,
  author = {Br, Vinay Kumar and Sarin, Shiv Kumar},
  title = {Acute-on-chronic liver failure: Terminology, mechanisms and management},
  journal = {Clinical and Molecular Hepatology},
  year = {2023},
  volume = {29},
  number = {3},
  pages = {670--689},
  doi = {10.3350/cmh.2022.0103}
}
Kostenlos starten →